Table 1

Characteristics, procedural metrics, and outcomes of stroke patients receiving mechanical thrombectomy before and during the COVID-19 pandemic

Thrombectomy patients during COVID-19 pandemic (n=235)Thrombectomy patients before COVID-19 pandemic (n=1848)P- value*
Age, median (IQR)71 (59–79)69 (58–79)0.058
Females, n (%)113 (48.1%)901 (48.8%)0.846
Racial/ethnic distribution: 0.01
 White, n (%)146 (62.1%)1047 (56.7%)
 African American, n (%)56 (23.8%)609 (32.9%)
 Hispanic, n (%)31 (13.2%)188 (10.2%)
 Others, n (%)2 (0.9%)4 (0.2%)
Admission NIHSS, median (IQR)16 (10–21)16 (10–21)0.898
IV-tPA, n (%)106 (45.1%)831 (45%)0.968
ASPECTS, median (IQR)†9 (7–10)9 (7–10)0.225
Posterior circulation occlusion, n (%)21 (8.9%)195 (10.6%)0.444
Symptom onset to groin in minutes, median (IQR)343 (202–576)288 (178–575)0.065
Number of passes, median (IQR)2 (1–3)2 (1–3)0.921
mTICI ≥2 b, n (%)196 (83.4%)1588 (85.9%)0.228
Procedure duration in minutes, median (IQR)44 (25–73)38 (21–63) 0.006
Procedure complications, n (%)20 (8.5%)163 (8.8%)0.874
sICH, n (%)15 (6.4%)108 (5.8%)0.741
Length of hospitalization in days, median (IQR)6 (3–10)4 (2–5) <0.001
DC mRS, median (IQR)4 (2–5)3 (2–4) 0.015
mRS 0–2 on discharge, n (%)77 (32.8%)637 (34.5%)0.604
In-hospital mortality, n (%)44 (18.7%)203 (11%) <0.001
  • *Calculated using chi-square test for categorical variables and Mann–Whitney U test for the continuous variables.

  • †Only for patients with anterior circulation occlusion.

  • ASPECTS, Alberta Stroke Program Early CT score; COVID-19, coronavirus disease of 2019; IQR, interquartile range; IV-tPA, intravenous tissue plasminogen activator; LKN, last known normal; mRS, modified Rankin Scale; mTICI, modified Thrombolysis in Cerebral Infarction; NIHSS, National Institute of Health Stroke Scale; sICH, symptomatic intracerebral hematoma.